Psychiatry and Neurology, Neurology · Reston, VA
NPI
1316110125
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1830 Town Center Dr, Suite 305
Reston, VA, 20190
Phone (703) 478-0601
Groups this clinician bills Medicare through
Medicare paid, 2024
$315K
1,650 services
Medicare patients, 2024
659
Average age 74
Drug cost, 2024
$517K
842 prescriptions
Company payments, 2025
$954
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard L Cho was code 99214 (office e&m - established), 630 times for 388 patients. In total Richard L Cho billed 1,650 services in 15 codes, and Medicare paid $315K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 630 | 388 | $105.41 | $66K |
| 99215 Office E&M - Established | Office | 389 | 262 | $149.09 | $58K |
| 95811 Sleep Study | Office | 156 | 129 | $585.77 | $91K |
| 95810 Sleep Study | Office | 104 | 104 | $550.90 | $57K |
| 99213 Office E&M - Established | Office | 103 | 76 | $73.53 | $7,573 |
| 99204 Office E&M - New | Office | 90 | 90 | $132.22 | $12K |
| 95800 Sleep Study | Office | 54 | 53 | $116.24 | $6,277 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 44 | $14.09 | $648 |
| 99205 Office E&M - New | Office | 32 | 32 | $187.26 | $5,992 |
| 99212 Office E&M - Established | Office | 17 | 15 | $47.58 | $809 |
By year: 2022 $299K for 1,695 services; 2023 $301K for 1,648 services; 2024 $315K for 1,650 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard L Cho prescribed most often to Medicare patients was Gabapentin, with 111 prescriptions and refills. In total Richard L Cho wrote 842 Medicare prescriptions that cost $517K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 111 | 197 | 37 | $1,149 |
| Zolpidem Tartrate Generic | 72 | 88 | 18 | $324 |
| Donepezil Hcl Generic | 55 | 107 | 17 | $578 |
| Modafinil Generic | 48 | 72 | 15 | $2,838 |
| Clonazepam Generic | 44 | 64 | Under 11 | $207 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 44 | 124 | 15 | $1,174 |
| Topiramate Generic | 26 | 49 | Under 11 | $523 |
| Memantine Hcl Generic | 25 | 51 | Under 11 | $593 |
| Lorazepam Generic | 24 | 31 | Under 11 | $185 |
| Xyrem Sodium Oxybate | 23 | 23 | Under 11 | $320K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 17 | 17 | Under 11 | $11K |
| Keppra Levetiracetam | 16 | 22 | Under 11 | $30K |
| Armodafinil Generic | 15 | 39 | Under 11 | $1,202 |
| Alprazolam Generic | 15 | 19 | Under 11 | $19.86 |
| Primidone Generic | 15 | 44 | Under 11 | $261 |
Brand drugs: 132 claims; generic drugs: 710 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard L Cho $954 ($954 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 8 | $197 |
| Harmony Biosciences LLC HRMY | 2 | $90.75 |
| Axsome Therapeutics, Inc. AXSM | 4 | $85.62 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $65.29 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $58.78 |
| Merz Pharmaceuticals, LLC | 2 | $53.51 |
| Lundbeck LLC | 2 | $51.58 |
| Idorsia Pharmaceuticals US Inc | 2 | $48.93 |
| Pfizer Inc. PFE | 2 | $44.35 |
| Life Molecular Imaging Ltd | 1 | $36.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.